跳至主要内容
临床试验/NL-OMON53885
NL-OMON53885招募中4 期

Prospective non-randomised post-market study collecting clinical data on safety and effectiveness of the remed*®-System - r*ST Study

Zoll Respicardia Inc.0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Moderate to severe central sleep apnea (AHI >= 15 events per hour) based on a
  • sleep study scored by a local sleep laboratory. It is strongly recommended that
  • a patient have a diagnostic PSG within 12 months of the expected implant date
  • documenting moderate to severe CSA.
  • -Age 18 years or older
  • -Signed approved informed consent
  • -In the opinion of the investigator, subject is willing and able to comply with
  • the protocol.
  • -Not currently enrolled in another investigational study or registry that would
  • directly interfere with the current study, except if the subject is
  • participating in a mandatory government registry, or a purely observational
  • registry with no associated treatments. Each instance should be brought to the
  • attention of the sponsor to determine eligibility.
  • -In the opinion of the Investigator, life expectancy exceeds one year.
  • -The subject is not pregnant or planning to become pregnant.

排除标准

  • The subject is pregnant or planning to become pregnant

研究者

相似试验